The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance of technologies such as machine learning, augmented reality, 5G and digitalisation. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Internet of Things in Medical Devices: Neuromuscular activity analysis.

However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.

Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.

150+ innovations will shape the medical devices industry

According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 550,000 patents, there are 150+ innovation areas that will shape the future of the industry.

Within the emerging innovation stage, ingestible sensors, wireless gastric stimulation devices, and remote nerve stimulation devices are disruptive technologies that are in the early stages of application and should be tracked closely. dosage monitoring inhalators, programmable infusion pumps, and athletic monitoring sensors are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are blood glucose sensors and medical emergency response systems, which are now well established in the industry. 

Innovation S-curve for Internet of Things in the medical devices industry

Neuromuscular activity analysis is a key innovation area in Internet of Things

Neuromuscular activity analysis is a profound method for monitoring neuromuscular transmission. It checks the neuromuscular function by stimulating a reachable peripheral motor nerve and further measures the evoked response of the muscles innervated by it. This evaluation method can be used to determine the health of muscles and related motor neurons, detect neuromuscular abnormalities and assess the cause of certain symptoms.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.  According to GlobalData, there are 660+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of neuromuscular activity analysis.

Key players in neuromuscular activity analysis – a disruptive innovation in the medical devices industry

‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Patent volumes related to neuromuscular activity analysis

Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies
Baxter International 2108 Unlock company profile
Koninklijke Philips 2068 Unlock company profile
Medtronic 1439 Unlock company profile
Abbott Laboratories 1085 Unlock company profile
Johnson & Johnson 962 Unlock company profile
DexCom 944 Unlock company profile
F. Hoffmann-La Roche 918 Unlock company profile
Samsung Group 905 Unlock company profile
Alphabet 507 Unlock company profile
Boston Scientific 502 Unlock company profile
NIKE 476 Unlock company profile
General Electric 387 Unlock company profile
Asahi Kasei 316 Unlock company profile
Omron 308 Unlock company profile
Becton Dickinson and Co 293 Unlock company profile
Stryker 290 Unlock company profile
Panasonic 286 Unlock company profile
Masimo 282 Unlock company profile
ResMed 271 Unlock company profile
Apple 260 Unlock company profile
Sony Group 245 Unlock company profile
International Business Machines 238 Unlock company profile
Siemens 236 Unlock company profile
PHC Holdings 218 Unlock company profile
Microsoft 209 Unlock company profile
Nihon Kohden 209 Unlock company profile
Aliphcom 201 Unlock company profile
Mortara Instrument 193 Unlock company profile
Smith & Nephew 188 Unlock company profile
Magic Leap 182 Unlock company profile
Valencell 173 Unlock company profile
Fujifilm Holdings 161 Unlock company profile
LG 161 Unlock company profile
Canon 148 Unlock company profile
Teva Pharmaceutical Industries 147 Unlock company profile
adidas 146 Unlock company profile
Qualcomm 139 Unlock company profile
Bigfoot Biomedical 137 Unlock company profile
Fresenius 134 Unlock company profile
Terumo 128 Unlock company profile
ARC Devices 123 Unlock company profile
Dragerwerk 119 Unlock company profile
Aseko 117 Unlock company profile
Shenzhen Mindray Bio-Medical Electronics 116 Unlock company profile
Intel 112 Unlock company profile
Seiko Epson 112 Unlock company profile
Sanofi 111 Unlock company profile
Konica Minolta 103 Unlock company profile
Beijing Electronics Holding 98 Unlock company profile
Bayer 98 Unlock company profile

Source: GlobalData Patent Analytics

Baxter International is one of the leading patent filers in the field of neuromuscular activity analysis. Some other key patent filers in the field include Koninklijke Philips and Medtronic.

In terms of application diversity, Teva Pharmaceutical Industries leads the pack, followed by ResMed and Microsoft. By means of geographic reach, Teva Pharmaceutical Industries holds the top position, followed by Stryker and NIKE in the second and third spots, respectively.

The rise in the number of neuromuscular disorders is increasing the need for adequate therapy that will reduce the risk of residual neuromuscular blockades leading to the overall growth of the neurology devices market. Neuromuscular activity analysis provides doctors with a crucial insight, enabling them to provide a more predictable and accurate treatment approach, thereby leading to improved patient care.

To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.